{"transactions":[{"id":881296,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-02-26T00:59:26.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":4949,"price":41.9839,"value":207778.3211,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The trading order for shares sold to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs) of all participants for the Issuer, including the Reporting Person, occurred over a period of two (2) business days, beginning on February 23, 2026 and ending on February 24, 2026."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to solely satisfy tax withholding obligations incurred upon vesting of restricted stock units. The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.005 to $42.84, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":114181,"source":{"system":"sec-edgar","filing":"0001872792-26-000004","document":"form4-02262026_120222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000187279226000004/form4-02262026_120222.xml","form_type":"4"}},{"id":915645,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-07T01:00:13.000Z","date":"2026-02-04","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the stock option will vest and become exercisable on March 4, 2026, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":42.74,"expiration_date":"2036-02-03","underlying":"Class A Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001872792-26-000002","document":"form4-02062026_080209.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000187279226000002/form4-02062026_080209.xml","form_type":"4"}},{"id":915644,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-02-07T01:00:13.000Z","date":"2026-02-04","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Class A Common Stock underlying the restricted stock units (\"RSUs\") granted under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of February 20, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continuous service through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 893 shares of Class A Common Stock acquired under the Issuer's 2021 Employee Stock Purchase Plan on September 12, 2025."}],"balance_after":119130,"source":{"system":"sec-edgar","filing":"0001872792-26-000002","document":"form4-02062026_080209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000187279226000002/form4-02062026_080209.xml","form_type":"4"}},{"id":1254773,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-20T21:08:57.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":53800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48 of the shares subject to the stock option will vest and become exercisable on March 18, 2025, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":53800,"derivative":{"exercise_price":29.18,"expiration_date":"2035-02-17","underlying":"Class A Common Stock","underlying_shares":53800},"source":{"system":"sec-edgar","filing":"0001415889-25-004846","document":"form4-02202025_090254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588925004846/form4-02202025_090254.xml","form_type":"4"}},{"id":1254772,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-02-20T21:08:57.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":26900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Class A Common Stock underlying the restricted stock units (\"RSUs\") under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of February 20, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":93237,"source":{"system":"sec-edgar","filing":"0001415889-25-004846","document":"form4-02202025_090254.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588925004846/form4-02202025_090254.xml","form_type":"4"}},{"id":1546359,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"exercise","planned":false,"acquired":false,"shares":99828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"1/4 of 180,000 shares subject to the option vested on July 12, 2022, and 1/48 of the shares vest monthly thereafter."}],"balance_after":80172,"derivative":{"exercise_price":14.87,"expiration_date":"2031-07-12","underlying":"Class A Common Stock","underlying_shares":99828},"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546358,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":6965,"price":40.057,"value":278997.005,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.82 to $40.355, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any\nsecurity holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546357,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":2944,"price":39.193,"value":115384.192,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $38.75 to $39.67, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any\nsecurity holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":11965,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546356,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":3112,"price":38.223,"value":118949.976,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $37.70 to $38.64, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any\nsecurity holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":14909,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546355,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":453,"price":40.054,"value":18144.462,"ownership":{"direct":false,"nature":"By Spouse's IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.82 to $40.355, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any\nsecurity holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546354,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":203,"price":39.197,"value":7956.991,"ownership":{"direct":false,"nature":"By Spouse's IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $38.75 to $39.67, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any\nsecurity holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":453,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546353,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":201,"price":38.231,"value":7684.431,"ownership":{"direct":false,"nature":"By Spouse's IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $37.70 to $38.64, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any\nsecurity holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":656,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546352,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":1505,"price":40.057,"value":60285.785,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.82 to $40.355, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any\nsecurity holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546351,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":639,"price":39.193,"value":25044.327,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $38.75 to $39.67, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any\nsecurity holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1505,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546350,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":672,"price":38.223,"value":25685.856,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $37.70 to $38.64, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any\nsecurity holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2144,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546349,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":867,"price":40.059,"value":34731.153,"ownership":{"direct":false,"nature":"As Custodian for UTMA account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.82 to $40.355, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any\nsecurity holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The shares were acquired through a custodial account established for an immediate family member of the Reporting Person pursuant to the Uniform Transfers to Minors Act, for which the Reporting Person serves as a custodian."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546348,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":366,"price":39.185,"value":14341.71,"ownership":{"direct":false,"nature":"As Custodian for UTMA account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $38.75 to $39.67, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any\nsecurity holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The shares were acquired through a custodial account established for an immediate family member of the Reporting Person pursuant to the Uniform Transfers to Minors Act, for which the Reporting Person serves as a custodian."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."}],"balance_after":867,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546347,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":387,"price":38.224,"value":14792.688,"ownership":{"direct":false,"nature":"As custodian for UTMA account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $37.70 to $38.64, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any\nsecurity holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The shares were acquired through a custodial account established for an immediate family member of the Reporting Person pursuant to the Uniform Transfers to Minors Act, for which the Reporting Person serves as a custodian."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."}],"balance_after":1233,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546346,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":177,"price":40.058,"value":7090.266,"ownership":{"direct":false,"nature":"By Roth IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.82 to $40.355, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any\nsecurity holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546345,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":80,"price":39.217,"value":3137.36,"ownership":{"direct":false,"nature":"By Roth IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $38.75 to $39.67, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any\nsecurity holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":177,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546344,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":78,"price":38.195,"value":2979.21,"ownership":{"direct":false,"nature":"By Roth IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $37.70 to $38.64, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any\nsecurity holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":257,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546343,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":7361,"price":39.251,"value":288926.611,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.075 to $39.35, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":66337,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546342,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":11648,"price":38.125,"value":444080.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.52, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":73698,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546341,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":10988,"price":38.652,"value":424708.176,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $38.25 to $39.225, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":85346,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546340,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"sale","planned":false,"acquired":false,"shares":69831,"price":40.051,"value":2796801.381,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.36, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":96334,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546339,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:32:12.000Z","date":"2024-04-03","kind":"exercise","planned":false,"acquired":true,"shares":99828,"price":14.87,"value":1484442.36,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,939 shares of Class A Common Stock acquired under the Issuer's 2021 Employee Stock Purchase Plan on March 13, 2024."}],"balance_after":166165,"source":{"system":"sec-edgar","filing":"0001415889-24-010473","document":"form4-04062024_010405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010473/form4-04062024_010405.xml","form_type":"4"}},{"id":1546338,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:27:39.000Z","date":"2023-07-24","kind":"gift","planned":false,"acquired":true,"shares":1620,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Custodian for UTMA account"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares were acquired through a custodial account established for an immediate family member of the Reporting Person pursuant to the Uniform Transfers to Minors Act, for which the Reporting Person serves as a custodian."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose."}],"balance_after":1620,"source":{"system":"sec-edgar","filing":"0001415889-24-010472","document":"form4-04062024_010432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010472/form4-04062024_010432.xml","form_type":"4"}},{"id":1546337,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:27:39.000Z","date":"2023-12-20","kind":"gift","planned":false,"acquired":false,"shares":636,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the number of shares held directly at the time and after giving effect to the reported gift."}],"balance_after":18021,"source":{"system":"sec-edgar","filing":"0001415889-24-010472","document":"form4-04062024_010432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010472/form4-04062024_010432.xml","form_type":"4"}},{"id":1546336,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:27:39.000Z","date":"2023-07-24","kind":"gift","planned":false,"acquired":false,"shares":1620,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the number of shares held by the trust at the time and after giving effect to the reported gift.  The number also reflects a purchase reported on a Form 4 filed on June 23, 2023."}],"balance_after":18657,"source":{"system":"sec-edgar","filing":"0001415889-24-010472","document":"form4-04062024_010432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010472/form4-04062024_010432.xml","form_type":"4"}},{"id":1546335,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:27:39.000Z","date":"2023-03-14","kind":"gift","planned":false,"acquired":true,"shares":14285,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the number of shares held by the trust at the time and after giving effect to the reported gift."}],"balance_after":15277,"source":{"system":"sec-edgar","filing":"0001415889-24-010472","document":"form4-04062024_010432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010472/form4-04062024_010432.xml","form_type":"4"}},{"id":1546334,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-04-06T01:27:39.000Z","date":"2023-03-14","kind":"gift","planned":false,"acquired":false,"shares":14285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the number of shares held directly at the time and after giving effect to the reported gift."}],"balance_after":35648,"source":{"system":"sec-edgar","filing":"0001415889-24-010472","document":"form4-04062024_010432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924010472/form4-04062024_010432.xml","form_type":"4"}},{"id":1675966,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-18T21:03:28.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":97500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of the shares subject to the stock option will vest and become exercisable on February 16, 2024, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":97500,"derivative":{"exercise_price":16.8,"expiration_date":"2034-01-15","underlying":"Class A Common Stock","underlying_shares":97500},"source":{"system":"sec-edgar","filing":"0001415889-24-001514","document":"form4-01182024_090121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924001514/form4-01182024_090121.xml","form_type":"4"}},{"id":1675965,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2024-01-18T21:03:28.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Class A Common Stock underlying the restricted stock units (\"RSUs\") under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs vest, rounded to the nearest whole share, on each of February 20, 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,500 shares of Class A Common Stock acquired under the Issuer's 2021 Employee Stock Purchase Plan on September 13, 2023."}],"balance_after":78683,"source":{"system":"sec-edgar","filing":"0001415889-24-001514","document":"form4-01182024_090121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000141588924001514/form4-01182024_090121.xml","form_type":"4"}},{"id":1844804,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-23T20:05:01.000Z","date":"2023-06-23","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":16.6,"value":83000.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":5992,"source":{"system":"sec-edgar","filing":"0001209191-23-039323","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919123039323/doc4.xml","form_type":"4"}},{"id":2006260,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-17T21:17:30.000Z","date":"2023-02-06","kind":"purchase","acquired":true,"shares":14285,"price":7,"value":99995.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The reporting person's original Form 4 contained a typographical error on the transaction date."},{"field":"shares","element":"transactionShares","label":"F2","text":"Shares purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 6, 2023.  The purchase price is the offering price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 380 shares acquired under the Issuer's Employee Stock Purchase Plan on September 13, 2022."}],"balance_after":49933,"source":{"system":"sec-edgar","filing":"0001209191-23-010583","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919123010583/doc4a.xml","form_type":"4/A","original_submission_date":"2023-02-08"}},{"id":2006256,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-17T21:10:21.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48 of the total stock option will vest and become exercisable monthly on the same day of each month following February 15, 2023, subject to continuous service of the Reporting Person on each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":7.87,"expiration_date":"2033-02-14","underlying":"Class A Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-23-010523","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919123010523/doc4.xml","form_type":"4"}},{"id":2026098,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-08T21:04:15.000Z","date":"2022-02-06","kind":"purchase","acquired":true,"shares":14285,"price":7,"value":99995.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 6, 2023.  The purchase price is the offering price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 380 shares acquired under the Issuer's Employee Stock Purchase Plan on September 13, 2022."}],"balance_after":49933,"source":{"system":"sec-edgar","filing":"0001209191-23-007769","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919123007769/doc4.xml","form_type":"4"}},{"id":2175684,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-23T20:06:15.000Z","date":"2022-08-19","kind":"grant","acquired":true,"shares":33750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Class A Common Stock underlying the restricted stock units (\"RSUs\") under Issuer's 2021 Equity Incentive Plan. One-third of the RSUs vest on August 20, 2023, rounded to the nearest whole share, and the remaining RSUs vest on August 20, 2024, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":35268,"source":{"system":"sec-edgar","filing":"0001209191-22-047164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122047164/doc4.xml","form_type":"4"}},{"id":2229366,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-06-16T20:06:32.000Z","date":"2022-06-15","kind":"purchase","acquired":true,"shares":992,"price":13.6008,"value":13491.9936,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were purchased in multiple transactions for all of Reporting Person's indirect accounts on the reported date with prices ranging from $13.05 to $13.85, resulting in a weighted average price of $13.6008. Upon request, the Reporting Person will provide to Issuer, the Commission staff or a security holder of the Issuer the number of shares purchased and the purchase price for each separate transaction."}],"balance_after":992,"source":{"system":"sec-edgar","filing":"0001209191-22-037401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122037401/doc4.xml","form_type":"4"}},{"id":2229365,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-06-16T20:06:32.000Z","date":"2022-06-15","kind":"purchase","acquired":true,"shares":857,"price":13.6008,"value":11655.8856,"ownership":{"direct":false,"nature":"By Spouse's IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were purchased in multiple transactions for all of Reporting Person's indirect accounts on the reported date with prices ranging from $13.05 to $13.85, resulting in a weighted average price of $13.6008. Upon request, the Reporting Person will provide to Issuer, the Commission staff or a security holder of the Issuer the number of shares purchased and the purchase price for each separate transaction."}],"balance_after":857,"source":{"system":"sec-edgar","filing":"0001209191-22-037401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122037401/doc4.xml","form_type":"4"}},{"id":2229364,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-06-16T20:06:32.000Z","date":"2022-06-15","kind":"purchase","acquired":true,"shares":335,"price":13.6008,"value":4556.268,"ownership":{"direct":false,"nature":"By Roth IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were purchased in multiple transactions for all of Reporting Person's indirect accounts on the reported date with prices ranging from $13.05 to $13.85, resulting in a weighted average price of $13.6008. Upon request, the Reporting Person will provide to Issuer, the Commission staff or a security holder of the Issuer the number of shares purchased and the purchase price for each separate transaction."}],"balance_after":335,"source":{"system":"sec-edgar","filing":"0001209191-22-037401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122037401/doc4.xml","form_type":"4"}},{"id":2229363,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-06-16T20:06:32.000Z","date":"2022-06-15","kind":"purchase","acquired":true,"shares":2816,"price":13.6008,"value":38299.8528,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were purchased in multiple transactions for all of Reporting Person's indirect accounts on the reported date with prices ranging from $13.05 to $13.85, resulting in a weighted average price of $13.6008. Upon request, the Reporting Person will provide to Issuer, the Commission staff or a security holder of the Issuer the number of shares purchased and the purchase price for each separate transaction."}],"balance_after":2816,"source":{"system":"sec-edgar","filing":"0001209191-22-037401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122037401/doc4.xml","form_type":"4"}},{"id":2384609,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-18T21:09:04.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48 of the total stock option will vest and become exercisable monthly on the same day of each month following February 16, 2022, subject to continuous service of the Reporting Person on each vesting date."}],"balance_after":90000,"derivative":{"exercise_price":20.94,"expiration_date":"2032-02-15","underlying":"Class A Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-22-011215","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919122011215/doc4.xml","form_type":"4"}},{"id":2632877,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":64668,"kind":"person","name":"Grant Sean","position":1,"cik":"0001872792","reported_name":"Grant Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-15T20:22:37.000Z","date":"2021-07-13","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to the option vest on July 12, 2022, and 1/48 of the shares vest monthly thereafter."}],"balance_after":180000,"derivative":{"exercise_price":14.87,"expiration_date":"2031-07-12","underlying":"Class A Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001209191-21-046781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831828/000120919121046781/doc4.xml","form_type":"4"}}]}